Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IOPAMIDOL vs IPATASERTIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IOPAMIDOL vs IPATASERTIB: Safety Overview

Metric IOPAMIDOL IPATASERTIB
Total FAERS Reports 2,145 125
Deaths Reported 194 20
Death Rate 9.0% 16.0%
Hospitalizations 705 95
Average Patient Age 59.3 yrs 61.7 yrs
% Female Patients 56.9% 57.0%
FDA Approval Date Apr 2, 1997 N/A
Manufacturer BRACCO DIAGNOSTICS INC N/A
Route INTRAVASCULAR N/A
Marketing Status Prescription N/A